Immunogenicity is a major problem with protein-based therapeutics due to circulating anti-drug antibody (ADA) production. ADA may lead to many clinical problems including allergic reactions, altered pharmacokinetic, reduced efficacy, etc. Thus, perform an immunogenicity testing to evaluate the ADA level induced by therapeutic protein drug is a necessary step in both clinical studies and post marketing clinical monitoring.

Creative Diagnostics has years of experience in Designing, Optimizing, and Validating ADA assays for biotech and pharma companies. Our assay kit development is surely up to the FDA standard and we can tailor our protocols in every major step of the assay development to fit your specific purposes. We are glad to make it accessible to all kinds of research and industrial clients.